Target intelligence / Profile preview

Zaire ebolavirus RNA-directed RNA polymerase L mRNA (EBOV L mRNA)

Target
EBOV L mRNA
Molecular classification
mRNA, Nucleic acid
01

Overview

The Zaire ebolavirus L polymerase mRNA is the messenger RNA transcript derived from the L gene of the Ebola virus (EBOV). It serves as the essential template for the translation of the Large (L) protein, which functions as the catalytic subunit of the viral RNA-dependent RNA polymerase (RdRp) complex (UniProt: P35263). This complex is indispensable for the viral life cycle, as it mediates both the transcription of viral genes and the replication of the negative-sense RNA genome within the host cell (PubMed: 20511202). Because the L protein is critical for viral survival and lacks a human homolog, its mRNA is a primary target for sequence-specific therapeutic interventions such as small interfering RNAs (siRNAs) and antisense oligonucleotides (PubMed: 20802499). Therapeutic agents like TKM-Ebola (TKM-100-802) utilize lipid nanoparticles to deliver siRNAs that specifically bind to and trigger the degradation of this mRNA via the RNA-induced silencing complex (RISC), thereby preventing the production of the L protein (The Lancet, 2010). By neutralizing the synthesis of the viral replication machinery, these drugs effectively halt the progression of the infection (Nature, 2015).

Other names
Ebola virus L gene mRNAZaire ebolavirus L polymerase mRNAEBOV L transcriptLarge protein mRNA
02

Mechanism of action

RNA interference-mediated degradation of viral mRNA or antisense-mediated translation inhibition

03

Biological functions

Viral protein translationViral replicationTemplate for protein synthesis
04

Disease associations

Ebola virus diseaseInfection
05

Safety considerations

Infusion-related reactionsPro-inflammatory cytokine releaseOff-target hybridization effectsLipid nanoparticle-associated toxicity
06

Interacting drugs

TKM-Ebola (TKM-100-802)

2 more in the full profile.

07

Biomarkers

EBOV RNA viral loadL protein expression levels

Beyond the preview

Go deeper on Zaire ebolavirus RNA-directed RNA polymerase L mRNA (EBOV L mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zaire ebolavirus RNA-directed RNA polymerase L mRNA (EBOV L mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call